Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

Sun exposure and cutaneous HPV infection found synergistic in skin cancers

Sun exposure and cutaneous HPV infection found synergistic in skin cancers

Dabrafenib offers improved progression-free survival for melanoma patients

Dabrafenib offers improved progression-free survival for melanoma patients

Asbestos and shift work boost work-related cancer deaths to over 8,000 a year in UK

Asbestos and shift work boost work-related cancer deaths to over 8,000 a year in UK

New drug is 'greatest advance' for basal cell skin cancer

New drug is 'greatest advance' for basal cell skin cancer

ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma

ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma

ASCO 2012: New BRAF inhibitor dabrafenib delays disease progression better than standard chemotherapy in patients with advanced melanoma

ASCO 2012: New BRAF inhibitor dabrafenib delays disease progression better than standard chemotherapy in patients...

ASCO 2012: Promising activity for new PD-1 targeted immune therapy

ASCO 2012: Promising activity for new PD-1 targeted immune therapy

Commonly used painkillers may protect against skin cancer

Commonly used painkillers may protect against skin cancer

Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers

Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers

Trial of new drug, dabrafenib, for advanced melanoma offers potential breakthrough in treatment of brain metastases

Trial of new drug, dabrafenib, for advanced melanoma offers potential breakthrough in treatment of brain metastases

More from ecancer